Cytoplasmic p53 polypeptide is associated with ribosomes

Our previous finding that the tumor suppressor p53 is covalently linked to 5.8S rRNA suggested functional association of p53 polypeptide with ribosomes. p53 polypeptide is expressed at low basal levels in the cytoplasm of normal growing cells in the G1 phase of the cell cycle. We report here that cytoplasmic wild-type p53 polypeptide from both rat embryo fibroblasts and MCF7 cells and the A135V transforming mutant p53 polypeptide were found associated with ribosomes to various extents. Treatment of cytoplasmic extracts with RNase or puromycin in the presence of high salt, both of which are known to disrupt ribosomal function, dissociated p53 polypeptide from the ribosomes. In immunoprecipitates of p53 polypeptide-associated ribosomes, 5.8S rRNA was detectable only after proteinase K treatment, indicating all of the 5.8S rRNA in p53-associated ribosomes is covalently linked to protein. While 5.8S rRNA linked to protein was found in the immunoprecipitates of either wild-type or A135V mutant p53 polypeptide associated with ribosomes, little 5.8S rRNA was found in the immunoprecipitates of the slowly sedimenting p53 polypeptide, which was not associated with ribosomes. In contrast, 5.8S rRNA was liberated from bulk ribosomes by 1% sodium dodecyl sulfate, without digestion with proteinase K, indicating that these ribosomes contain 5.8S rRNA, which is not linked to protein. Immunoprecipitation of p53 polypeptide coprecipitated a small fraction of ribosomes. p53 mRNA immunoprecipitated with cytoplasmic p53 polypeptide, while GAPDH mRNA did not. These results show that cytoplasmic p53 polypeptide is associated with a subset of ribosomes, having covalently modified 5.8S rRNA.

[1]  E. Appella,et al.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[3]  W. Maltzman,et al.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.

[4]  D. Lane,et al.  Cancer. p53, guardian of the genome. , 1992, Nature.

[5]  O. Halevy,et al.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.

[6]  A. Levine,et al.  The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes , 1994, Molecular and cellular biology.

[7]  J. Hurwitz,et al.  Role of polymeric forms of the bacteriophage phi X174 coded gene A protein in phi XRFI DNA cleavage. , 1979, The Journal of biological chemistry.

[8]  G. Lozano,et al.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.

[9]  J. Darnell,et al.  Characterization of a new low molecular weight RNA in HeLa cell ribosomes. , 1968, Journal of molecular biology.

[10]  N. Pavletich,et al.  Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms , 1995, Science.

[11]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Pabo,et al.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. , 1993, Genes & development.

[13]  A. De Benedetti,et al.  Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Michael E. Greenberg,et al.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene , 1984, Nature.

[15]  R. Carroll,et al.  Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Kozak,et al.  Regulation of translation in eukaryotic systems. , 1992, Annual review of cell biology.

[17]  Rotter,et al.  Meth A fibrosarcoma cells express two transforming mutant p53 species. , 1988, Oncogene.

[18]  R. Carroll,et al.  The tumor suppressor p53 is bound to RNA by a stable covalent linkage , 1991, Molecular and cellular biology.

[19]  E. Gurney,et al.  Time-dependent maturation of the simian virus 40 large T antigen-p53 complex studied by using monoclonal antibodies , 1982, Journal of virology.

[20]  S. Lindquist,et al.  Selective translation and degradation of heat-shock messenger RNAs in Drosophila. , 1990, Enzyme.

[21]  M. Werner-Washburne,et al.  The translation machinery and 70 kd heat shock protein cooperate in protein synthesis , 1992, Cell.

[22]  S. Lindquist,et al.  The preferential translation of Drosophila hsp70 mRNA requires sequences in the untranslated leader , 1985, Cell.

[23]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[24]  A. Levine,et al.  Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids , 1995, Molecular and cellular biology.

[25]  Leland Hartwell,et al.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells , 1992, Cell.

[26]  N. Craig.  Regulation of translation in rabbit reticulocytes and mouse L‐cells; comparison of the effects of temperature , 1976, Journal of cellular physiology.

[27]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[28]  I. Wool,et al.  Identification by affinity chromatography of the eukaryotic ribosomal proteins that bind to 5 S ribosomal ribonucleic acid. , 1979, The Journal of biological chemistry.

[29]  A. Hinnebusch,et al.  Phosphorylation of initiation factor 2α by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast , 1992, Cell.

[30]  G. Thireos,et al.  Coupling of GCN4 mRNA translational activation with decreased rates of polypeptide chain initiation , 1989, Cell.

[31]  A. Levine,et al.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.

[32]  V. Rotter,et al.  Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. , 1990, Oncogene.

[33]  J. E. Stenger,et al.  p53 domains: identification and characterization of two autonomous DNA-binding regions. , 1993, Genes & development.

[34]  M. Remm,et al.  A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. , 1992, Oncogene.

[35]  S. Fields,et al.  Presence of a potent transcription activating sequence in the p53 protein. , 1990, Science.

[36]  M. Katze,et al.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.

[37]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[38]  M. Rogers,et al.  Amphibian ribosomal ribonucleic acids. , 1972, The Biochemical journal.

[39]  C. Dang,et al.  A potential transcriptional activation element in the p53 protein. , 1990, Oncogene.

[40]  P. Friedman,et al.  The p53 protein is an unusually shaped tetramer that binds directly to DNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Katze,et al.  Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[43]  p53 is covalently linked to 5.8S rRNA. , 1992, Molecular and cellular biology.

[44]  X. Chen,et al.  A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. , 1993, Genes & development.

[45]  A. Metspalu,et al.  The ternary complex consisting of rat liver ribosomal 5 S RNA, 5.8 S RNA and protein L5 , 1980, FEBS letters.

[46]  M. Katze,et al.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Hershey,et al.  Translational control in mammalian cells. , 1991, Annual review of biochemistry.

[48]  M. Ewen,et al.  p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest. , 1995, Genes & development.

[49]  A. Levine,et al.  The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  U. Ramsperger,et al.  p53‐catalyzed annealing of complementary single‐stranded nucleic acids. , 1993, The EMBO journal.

[51]  Sherif Abou Elela,et al.  Inhibition of protein synthesis by anti-5.8 S rRNA oligodeoxyribonucleotides. , 1990, The Journal of biological chemistry.

[52]  M. Oren,et al.  Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein , 1991, Molecular and cellular biology.

[53]  A. Levine,et al.  Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex , 1986, Journal of virology.

[54]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[55]  D. Givol,et al.  The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. , 1985, The EMBO journal.

[56]  V. Rotter,et al.  Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis , 1990, Molecular and cellular biology.

[57]  D. Givol,et al.  Analysis of the gene coding for the murine cellular tumour antigen p53. , 1984, The EMBO journal.

[58]  A. Gronenborn,et al.  High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. , 1994, Science.

[59]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.